tetano
Editor, Senior Moderator
SAGE Open Med
. 2021 Jan 27;9:2050312121989504.
doi: 10.1177/2050312121989504. eCollection 2021.
Reviewing immunopathology characteristics of SARS-CoV-2 for cancer entwisted with SARS-CoV-2
Hongyan Li[SUP] 1 [/SUP], Wanting Lu[SUP] 2 [/SUP], Yinyin Li[SUP] 3 [/SUP], Yinying Lu[SUP] 3 [/SUP], Fei Li[SUP] 1 [/SUP]
Affiliations
Abstract
In December 2019, the outbreak of a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), infection that started in Wuhan, Hubei Province, China, has spread to all world. Based on the accumulated data and knowledge on the coronavirus infection and immunology characteristics, this review would hope to give some hints on human immune response to SARS-CoV-2 infection in cancer patients. This insight may help in designing the appropriate immune intervention for treatment and the prophylactic/therapeutic methods against cancer under current coronavirus from immunopathology characteristics of SARS-CoV-2 and cancer entwisted with it. We should achieve accurate diagnosis and treatment for cancer patients through advantages of multidisciplinary diagnosis and treatment team. It is believed that we will eventually overcome the epidemic and win in the future.
Keywords: China; SARS-CoV-2; cancer; coronavirus; immunopathology.
. 2021 Jan 27;9:2050312121989504.
doi: 10.1177/2050312121989504. eCollection 2021.
Reviewing immunopathology characteristics of SARS-CoV-2 for cancer entwisted with SARS-CoV-2
Hongyan Li[SUP] 1 [/SUP], Wanting Lu[SUP] 2 [/SUP], Yinyin Li[SUP] 3 [/SUP], Yinying Lu[SUP] 3 [/SUP], Fei Li[SUP] 1 [/SUP]
Affiliations
- PMID: 33552515
- PMCID: PMC7844443
- DOI: 10.1177/2050312121989504
Abstract
In December 2019, the outbreak of a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), infection that started in Wuhan, Hubei Province, China, has spread to all world. Based on the accumulated data and knowledge on the coronavirus infection and immunology characteristics, this review would hope to give some hints on human immune response to SARS-CoV-2 infection in cancer patients. This insight may help in designing the appropriate immune intervention for treatment and the prophylactic/therapeutic methods against cancer under current coronavirus from immunopathology characteristics of SARS-CoV-2 and cancer entwisted with it. We should achieve accurate diagnosis and treatment for cancer patients through advantages of multidisciplinary diagnosis and treatment team. It is believed that we will eventually overcome the epidemic and win in the future.
Keywords: China; SARS-CoV-2; cancer; coronavirus; immunopathology.